Schedule I
Schedule I is the most restrictive category in the U.S. federal Controlled Substances Act. It covers substances the law defines as having high abuse potential, no currently accepted medical use in the United States, and no accepted safety for use under medical supervision. Psilocybin is federally Schedule I.
- Federal category
- Part of the Controlled Substances Act
- Legal criteria
- Abuse potential, use, and safety
- Psilocybin
- Federally listed in Schedule I
- State programs
- Oregon and Colorado have supervised access
- Research
- May occur with federal authorization
What does Schedule I mean?
Schedule I is one of five categories in the federal Controlled Substances Act, the 1970 law that sets rules for certain drugs and chemicals. The law says a substance belongs in this category when it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and no accepted safety for use under medical supervision. Those are legal standards, not a general measure of a substance’s risks or a claim about every individual’s experience.
The category places strict limits on activities such as making, distributing, and possessing listed substances under federal law. It does not mean that research is impossible: researchers can seek the required federal approvals and registrations. Nor is Schedule I simply a ranking of how dangerous a substance is. The Controlled Substances Act has separate categories, and each has its own legal criteria and controls.
- 1Start review
DEA begins a review or receives a scheduling petition.
- 2Gather evidence
The agency collects information about the substance.
- 3Request HHS review
HHS evaluates scientific and medical information.
- 4Consider findings
DEA reviews HHS’s recommendation and other available material.
- 5Issue a decision
A proposed rule may invite comments before a final rule.
How does a substance enter Schedule I?
Congress created the original schedules when it passed the Controlled Substances Act. Changes can also follow a review process involving the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS). The DEA may start a review itself or receive a petition from an interested party. It gathers information and asks HHS for a scientific and medical evaluation.
HHS provides its evaluation and recommendation, and the DEA considers that material along with other available information before deciding whether to propose a scheduling change. If the process moves forward, the agency generally publishes a proposed rule and allows public input before a final rule. Congress can also change a substance’s status directly through legislation. The route depends on the specific action and legal authority involved.
Schedule I is a federal classification, though states may set separate rules.
Federal law places tight limits on listed substances.
Research can occur with required federal approvals and controls.
Editorial placement to help compare; not a measurement.
Why does Schedule I matter for psilocybin?
Psilocybin, the compound found in some mushrooms, remains in federal Schedule I in the United States as of November 2026. That federal status means its possession, manufacture, and distribution are generally prohibited unless an applicable legal authorization or exception applies. Researchers may work with it only under relevant approvals and controls; its research status does not make ordinary possession or sales federally lawful.
Some states have created separate pathways for supervised psilocybin access. Oregon and Colorado have state programs, while New Mexico’s medical program is being set up. These programs do not change psilocybin’s federal classification, and their rules differ from one another. A state policy or local decriminalization measure should not be mistaken for federal legalization or a general permission to buy, sell, or possess psilocybin.
| Schedule I | Schedule II | State program | |
|---|---|---|---|
| Legal basis | Federal drug schedule | Federal drug schedule | State-specific framework |
| Medical use | Not currently accepted federally | Accepted use under federal criteria | Depends on program rules |
| Prescribing | Cannot be prescribed under CSA | May be prescribed under controls | Access follows state program rules |
| Psilocybin | Federally Schedule I | Not federally Schedule II | Oregon and Colorado programs |
What are common Schedule I misconceptions?
A common misunderstanding is that Schedule I means a substance can never be studied or used in any legally permitted setting. Research can be allowed under federal controls, and state programs may authorize supervised access within their own rules. Another misconception is that the category itself proves a substance has no possible benefit. It describes a legal classification under federal criteria; it is not a complete summary of ongoing research or a personal medical recommendation.
The reverse assumption can also cause confusion: a state program does not erase federal law. Rules may change, and details about who may participate and where services can occur depend on the jurisdiction. Schedule I status also does not establish that a mushroom found outdoors is safe. Never eat a wild mushroom without expert identification; poisonous species can resemble those people seek.
- 1970
The Controlled Substances Act established the federal scheduling system and placed psilocybin in Schedule I.
- 1971
The Controlled Substances Act took effect.
- 2020
Oregon voters approved Measure 109, creating a state framework for supervised psilocybin services.
- 2022
Colorado voters approved Proposition 122, establishing a state natural-medicine framework.
- 2023
Oregon’s first licensed psilocybin service centers began operating.
How does Schedule I connect to mushroom topics?
Schedule I is a legal term, while words such as psilocybin, psilocin, and Psilocybe refer to a chemical or types of fungi. Psilocybin is the federally scheduled compound; a mushroom’s appearance or name alone does not settle its legal status. Mushroom identification is a separate skill from understanding drug law, and both can matter when people encounter wild species or information about them.
Related topics include decriminalization, state service centers, and the Controlled Substances Act’s scheduling process. Decriminalization generally means reducing or deprioritizing certain penalties, not creating a regulated legal market. Oregon’s Measure 109 and Colorado’s Proposition 122 established state frameworks with specific rules. To understand a particular activity, check current federal law and the applicable state and local requirements rather than relying on the label Schedule I alone.
Common questions about Schedule I
Is Schedule I the same as illegal?
Schedule I is a federal legal classification, not a complete description of every state or local rule. Federal law generally prohibits unauthorized possession and distribution of listed substances, while research and some state-regulated programs may operate under specific permissions. A state policy does not automatically change federal law.
Is psilocybin a Schedule I drug?
Yes. Psilocybin remains in Schedule I under U.S. federal law as of November 2026. That federal classification applies even though Oregon and Colorado have state programs for supervised access. New Mexico’s medical program is being set up, but state-level changes do not alter the federal schedule.
Can a doctor prescribe a Schedule I drug?
A Schedule I substance cannot be prescribed under the Controlled Substances Act in the same way as a medication in a schedule that permits prescribing. Federally authorized research is a separate matter and involves approvals and controls. State program access, where available, follows that state’s rules rather than a standard prescription.
What makes a drug Schedule I?
The Controlled Substances Act describes three criteria: high potential for abuse, no currently accepted medical use in treatment in the United States, and lack of accepted safety for use under medical supervision. These are legal standards used in federal scheduling, not a simple scale of danger or a statement about every person’s experience.
Related terms
Explore on Pscilly
Sources and further reading
- Wikipedia: Controlled Substances Act
- Oregon Health Authority: Oregon Psilocybin Services
- DEA: Drug Scheduling
Written by the Pscilly editorial team and reviewed November 2026. Educational content only, not medical or legal advice. Pscilly does not sell psilocybin. Never eat a wild mushroom without expert identification.